Showing 117 of 117on this page. Filters & sort apply to loaded results; URL updates for sharing.117 of 117 on this page
ARIAD completes NDA submission for brigatinib - BioTuesdays
Takeda acquires Ariad Pharmaceuticals - Pharma Journalist
Consultas de Especialidade | ARIAD Clínicas
Ariad Pharmaceuticals Offices - Cambridge | Office Snapshots
US Headquarters – ARIAD Pharmaceuticals – Chan Mock Architects LLC
ARIAD Announces Initiation of Randomized, First-Line Phase 3 Trial of ...
Ariad Logo My_Home_Page
Ariad Pharmaceuticals Photos and Premium High Res Pictures - Getty Images
Brand New: New Logo and Identity for Ariad by SKINN
ARIAD Pharmaceuticals Company Profile - Office Locations, Competitors ...
ARIAD - Rebranding :: Behance
Ariad, a new brand with the same spirit | Ariad
ARIA 代表 Ariad 制药公司 - Ariad Pharmaceuticals, Inc.
Ariad touts next generation CML treatment - Pharmafile
Takeda to buy Ariad for $5.2bn | pharmaphorum
Takeda to Buy Ariad Pharmaceuticals for $5.2 Billion | Fortune
ARIAD Pharmaceuticals Culture | Comparably
Incyte and ARIAD Announce Agreement for Incyte to Acquire ARIAD’s ...
ARIAD Pharmaceuticals: Transforming technology to… | PA Consulting
Agende Online - ARIAD Clínicas
COLLABORATION AGREEMENT between ARIAD Pharmaceuticals, Inc. | ARIAD ...
Ariad Pharmaceuticals | Sladen Feinstein
ARIAD Pharmaceuticals - Wikipedia
Centro Integral ARIAD
Ariad Partners Reviews & Ratings | Goodfirms
A letter from the directors: Ariad and NedWorks Join Forces to Shape ...
Employment Verification for Ariad Pharmaceuticals | Truv
Ariad Pharmaceuticals shares skyrocket more than 70 percent on word of ...
ARIAD Pharmaceuticals Inc - ARIA Stock Chart Technical Analysis for 11 ...
FDA designates Ariad Pharmaceuticals' lung cancer drug AP26113 as ...
Laboratorio Optico Ariad
Ariad Pharmaceuticals, Inc Earnings: Cloudy Future Drains Enthusiasm ...
ARIAD Clínicas | Alcochete
Ariad Health
ARIAD Pharmaceuticals Inc - ARIA Stock Chart Technical Analysis for 12 ...
Japan's Takeda to buy US cancer drug maker Ariad in $5.2 billion deal
Home | Ariad
ARIA Stock Report - ARIAD Pharmaceuticals, Inc.
Beyond the logo: 6 lessons from a rebrand | Ariad
Takeda Pharmaceutical to buy Ariad in $4.7 billion cash deal | Crain's ...
Sawtooth Glass Wall | Ariad Pharmaceuticals | Paul Housberg
Why Ariad Pharmaceuticals Shares Jumped 11.2% In February | Fox Business
Takeda Completes Acquisition of ARIAD Pharmaceuticals Inc
Ariad | Partners International
ARIAD Pharmaceuticals-ARIAD Pharmaceuticals, Inc-企业详情-InvestGO数据库 ...
Ariad Pharma Could Draw M&A Fire Ahead Of Second Cancer Drug Win ...
Ariad files early marketing application for brigatinib - PMLiVE
Takeda to Acquire ARIAD Pharmaceuticals | Business Post Nigeria
Ariad Partners, LLC
ARIAD Announces Marketing Authorization for Iclusig® (ponatinib) in the ...
Ariad Clínicas | Clínica Médica em Alcochete
Análises Clínicas | ARIAD Clínicas | Marcação rápida
ARIAD announces that Iclusig(TM) receives positive CHMP opinion for ...
Intralinks for Life Sciences M&A | Intralinks
The Bowdoin Group Completes Commercial Expansion for ARAID ...
Prosource joins Ariad: expanding their expertise in Digital Marketing ...
ARIA.-Ariad Pharmaceuticals, Inc.....¡TNT!, lo que puede pasar aquí ...
Economics & World Government
Cambridge office design | Office Snapshots
